Medtech Global (ASX:MDG) has finalised the sale of its Medtech Evolution practice management software to Nirvana Group, one of Auckland's largest healthcare groups.
Nirvana has agreed to use Medtech in all 22 of its general practice clinics to replace Medtech's previous software offering.
Medtech operates several cloud-based health and health insurance solutions and is capitalised at around $20 million.
The stock has been a quiet achiever over the past year, rising over 7-fold since October last year to its current price of $0.20.
Medtech notched revenue of $5,090,000 during the most recent quarter, with positive cash flow of $505,000 and retained cash of $1.6 million.
